PetVivo Holdings terminates CEO

Workflow Solutions
Products
See more S&P Global Solutions
See More IHS Markit Solutions
Content
How We Can Help
See More
News & Insights Topics
See More
Featured Events
Webinar ReplaysNew Corporate Realities: Blending Geopolitics, Data, and Digital Transformation
- 07/21/2022
- On-Demand
- 1 Hour
In PersonInteract 2022
- 09/15/2022
- 225 Liberty Street, New York, New York
- 225 Liberty Street
In Person451Nexus
- 10/03/2022
- ARIA Resort and Casino, Las Vegas, Nevada
Platforms
Other Products
- Leveraged Commentary and Data
- Research Online

In This List

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations

12 Dec, 2018

Author Fatima Aitizaz
Theme Healthcare & Pharmaceuticals

The board of PetVivo Holdings Inc. terminated CEO Wesley Hayne, effective Dec. 3.

The company's board assumed the roles and responsibilities of CEO. In addition, the company's controller John Carruth was named acting CFO.

Edina, Minn.-based PetVivo Holdings is a biomedical device company focused on the licensing and commercialization of medical devices and therapeutics for pets and other animals suffering from arthritis and other afflictions.